Gaudium IVF & Women Health
Table of Contents
- 01 IPO Description
- 02 IPO Parameters
- 03 IPO Roadmap
- 04 GMP History
- 05 Gaudium IVF IPO – Key Details
- 06 Gaudium IVF IPO – Market Lot Details
- 07 Gaudium IVF IPO – Reservation Details
- 08 Gaudium IVF IPO – Anchor Investors Details
- 09 Gaudium IVF IPO – Important Dates
- 10 Gaudium IVF IPO – Promoters & Holding Pattern
- 11 Gaudium IVF IPO – Objects of the Issue & Utilisation of Proceeds
- 12 About Gaudium IVF IPO
- 13 Gaudium IVF IPO – Company Financial Report
- 14 Gaudium IVF IPO – Valuation (FY2025)
- 15 Peer Group Comparison
- 16 IPO Lead Managers aka Merchant Bankers
IPO PARAMETERS
IPO ROADMAP
Grey Market Premium HISTORY
| Date | GMP (₹) | Daily Change | Gain (%) |
|---|---|---|---|
| 18 Feb 2026 | ₹12.50 | - | 15.82% |
Gaudium IVF IPO – Key DETAILS
| IPO Open Date | February 20, 2026 |
| IPO Close Date | February 24, 2026 |
| Face Value | ₹5 Per Equity Share |
| IPO Price Band | ₹75 to ₹79 Per Share |
| Issue Size | Approx ₹165 Crores |
| Fresh Issue | Approx ₹90 Crores |
| Offer for Sale (OFS) | Approx 94,93,700 Equity Shares |
| Issue Type | Book Build Issue |
| IPO Listing | BSE, NSE |
Gaudium IVF IPO – Market Lot DETAILS
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 189 | ₹14,931 |
| Retail Maximum | 13 | 2,457 | ₹1,94,103 |
| S-HNI Minimum | 14 | 2,646 | ₹2,09,034 |
| S-HNI Maximum | 66 | 12,474 | ₹9,85,446 |
| B-HNI Minimum | 67 | 12,663 | ₹10,00,377 |
Gaudium IVF IPO – Reservation DETAILS
| Investor Category | Shares Offered | Reservation (%) |
|---|---|---|
| Anchor Investor | – | – |
| QIB (Ex. Anchor) | – | 50% |
| NII | – | 15% |
| Retail | – | 35% |
Gaudium IVF IPO – Anchor Investors DETAILS
| Anchor Bidding Date | February 18, 2026 |
| Shares Offered to Anchor Investors | – |
| Anchor Portion Size | – |
| Lock-in Period (50% Shares – 30 Days) | March, 2026 |
| Lock-in Period (50% Shares – 90 Days) | May, 2026 |
Gaudium IVF IPO – Important DATES
| IPO Open Date | February 20, 2026 |
| IPO Close Date | February 24, 2026 |
| Basis of Allotment | February 25, 2026 |
| Refunds Initiation | February 26, 2026 |
| Credit to Demat Account | February 26, 2026 |
| IPO Listing Date | February 27, 2026 |
| IPO Bidding Cut-off Time | February 24, 2026 – 5 PM |
Gaudium IVF IPO – Promoters & Holding PATTERN
| Promoters | Dr. Manika Khanna, Dr. Peeyush Khanna, Vishad Khanna |
| Promoter Holding (Pre Issue) | 6,13,94,384 Shares (99.98%) |
| Promoter Holding (Post Issue) | 7,27,86,884 Shares |
Gaudium IVF IPO – Objects of the Issue & Utilisation of PROCEEDS
| Funding capital expenditure towards establishment of New IVF Centers of the Company | ₹50 Cr |
| Repayment / pre-payment, in full or in part, of certain outstanding loans availed by the Company | ₹20 Cr |
| General Corporate Purpose | – |
About Gaudium IVF IPO
Gaudium IVF, founded in March 2015, is one of the leading companies offering In Vitro Fertilization (IVF) treatments for women across India. The company operates its business over 30 locations, with seven hubs (centres) and twenty-eight spokes. The firm treats its patients in various countries, including Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
The firm offers various fertility services such as Vitro Fertilisation (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction. Its treatments are targeted towards both genders. Moreover, the firm also provides PCOD/PCOS, endometriosis, and special care for women in pregnancy with complex fertility issues. Gaudium IVF also offers treatments targeting male infertility, including advanced sperm retrieval procedures.
Gaudium IVF IPO – Company Financial REPORT
| Period Ended | Revenue (₹ Cr) | Expense (₹ Cr) | PAT (₹ Cr) | Assets (₹ Cr) |
|---|---|---|---|---|
| 2023 | 44.26 | 25.95 | 13.53 | 36.63 |
| 2024 | 48.15 | 31.52 | 10.32 | 51.01 |
| 2025 | 70.96 | 45.54 | 19.13 | 88.51 |
| Sep 2025 | 49.75 | 32.97 | 12.51 | 106.62 |
Gaudium IVF IPO – Valuation (FY2025)
| ROE | 41.31% |
| ROCE | 39.70% |
| EBITDA Margin | 40.48% |
| PAT Margin | 26.96% |
| Debt to Equity Ratio | 0.41 |
| Earning Per Share (EPS) | ₹3.12 (Basic) |
| Price / Earning (P/E) Ratio | N/A |
| Return on Net Worth (RoNW) | 41.71% |
| Net Asset Value (NAV) | ₹7.54 |
Peer Group COMPARISON
- There is no listed industry peers available.
IPO Lead Managers aka Merchant BANKERS
- Sarthi Capital Advisors Pvt. Ltd.